Views & Analysis Digital Health Round-up – pharma to build Moonshot database,... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Shire's Onivyde pancreatic cancer drug approved in EU Drug approved in metastatic adenocarcinoma of the pancreas.
Views & Analysis ESMO review: advances in immunotherapy, EMA dialogue and pa... QuintilesIMS’s Cristina Oliva talks to pharmaphorum about her personal highlights from this year’s congress.
News Lilly's Lartruvo approved in US for soft tissue sarcoma Eli Lilly’s 'breakthrough' drug for soft tissue sarcoma, Lartruvo, has been approved by the FDA.
News Kite outlines vision for next gen cancer killing cells Backed by Amgen, Kite outlines bold plan for developing CAR-T and TCR cells.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
